Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adocia SA stock logo
ADOCY
Adocia
$11.80
$11.80
$9.80
$11.80
$82.85M0.97N/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
$2.17
+7.4%
$1.71
$1.14
$4.84
$91.84M2.05377,648 shs456,377 shs
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
$3.15
+1.9%
$3.37
$1.52
$16.94
$82.16M2.31802,746 shs20,443 shs
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
$0.15
$0.15
$0.12
$0.18
$21.42M2.568,250 shsN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adocia SA stock logo
ADOCY
Adocia
0.00%0.00%0.00%0.00%0.00%
CareCloud, Inc. stock logo
CCLD
CareCloud
+7.43%+5.34%+15.12%-30.45%-27.42%
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
+1.94%-4.83%-5.12%-0.63%+5.14%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.00%0.00%0.00%0.00%+13,536.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Adocia SA stock logo
ADOCY
Adocia
N/AN/AN/AN/AN/AN/AN/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
2.9512 of 5 stars
2.25.00.00.02.80.82.5
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
2.8802 of 5 stars
3.55.00.00.01.80.01.3
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adocia SA stock logo
ADOCY
Adocia
0.00
N/AN/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
2.33
Hold$2.5015.21% Upside
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
3.00
Buy$12.00280.95% Upside
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TRXDW, CCLD, SNTI, and ADOCY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
5/2/2025
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/14/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $1.50
3/13/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$1.50
(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adocia SA stock logo
ADOCY
Adocia
$6.55M12.65N/AN/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
$112.51M0.82$0.38 per share5.76$2.63 per share0.83
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
$2.56M32.09N/AN/A$15.02 per share0.21
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
$8.53M2.51$0.11 per share1.40$2.68 per share0.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adocia SA stock logo
ADOCY
Adocia
-$22.90MN/A0.00N/AN/AN/AN/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
-$48.67M-$0.22N/A2.58N/A-35.25%-87.98%-50.79%8/12/2025 (Estimated)
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
-$71.06M-$10.84N/AN/AN/AN/A-154.84%-77.42%8/12/2025 (Estimated)
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
-$154.20M-$4.22N/AN/AN/A-2,149.15%-83.74%-64.94%N/A

Latest TRXDW, CCLD, SNTI, and ADOCY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
CareCloud, Inc. stock logo
CCLD
CareCloud
$0.09$0.05-$0.04-$0.04$25.94 million$27.60 million
5/6/2025Q1 2025
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
-$0.56-$1.41-$0.85-$1.41$1.30 million$1.30 million
3/20/2025Q4 2024
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
-$3.13-$0.67+$2.46-$0.67$2.80 million$5.86 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Adocia SA stock logo
ADOCY
Adocia
N/AN/AN/AN/AN/A
CareCloud, Inc. stock logo
CCLD
CareCloud
N/AN/AN/AN/AN/A
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
N/AN/AN/AN/AN/A
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adocia SA stock logo
ADOCY
Adocia
N/A
0.92
0.89
CareCloud, Inc. stock logo
CCLD
CareCloud
N/A
1.03
1.01
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
N/A
1.92
1.92
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.04
3.24
2.30

Institutional Ownership

CompanyInstitutional Ownership
Adocia SA stock logo
ADOCY
Adocia
N/A
CareCloud, Inc. stock logo
CCLD
CareCloud
10.16%
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
25.73%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
8.22%

Insider Ownership

CompanyInsider Ownership
Adocia SA stock logo
ADOCY
Adocia
N/A
CareCloud, Inc. stock logo
CCLD
CareCloud
14.70%
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
3.12%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
3.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Adocia SA stock logo
ADOCY
Adocia
787.02 millionN/ANot Optionable
CareCloud, Inc. stock logo
CCLD
CareCloud
4,10042.32 million10.01 millionOptionable
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
426.08 million4.30 millionNot Optionable
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/A142.78 millionN/ANot Optionable

Recent News About These Companies

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Adocia stock logo

Adocia OTCMKTS:ADOCY

$11.80 0.00 (0.00%)
As of 06/2/2025

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CareCloud stock logo

CareCloud NASDAQ:CCLD

$2.17 +0.15 (+7.43%)
Closing price 06/3/2025 04:00 PM Eastern
Extended Trading
$2.13 -0.04 (-1.89%)
As of 06/3/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Senti Biosciences stock logo

Senti Biosciences NASDAQ:SNTI

$3.15 +0.06 (+1.94%)
Closing price 06/3/2025 03:59 PM Eastern
Extended Trading
$3.12 -0.03 (-1.11%)
As of 06/3/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

TransEnterix stock logo

TransEnterix OTCMKTS:TRXDW

$0.15 0.00 (0.00%)
As of 03/7/2025

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.